FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079334384> ?p ?o ?g. }

• W2079334384 endingPage "946" @default.
• W2079334384 startingPage "939" @default.
• W2079334384 abstract "Objective Although the major cause of morbidity and mortality in patients with diabetes mellitus (DM) is cardiovascular disease, DM is also associated with certain site-specific cancers. However, whether DM is associated with an increased risk of cancer of the digestive tract remains undetermined. A nationwide, population-based database in Taiwan was analyzed to explore the relationship between DM and cancer of the digestive organs. Methods From 2000 to 2007, a study cohort consisting of 39,515 patients with newly diagnosed diabetes without a previous diagnosis of gastrointestinal (GI) cancer was identified from the National Health Insurance Research Database in Taiwan. A control cohort of 79,030 age- and sex-matched non-diabetic subjects was selected to compare the occurrence of GI malignancies between the two groups. The association between the incidence of GI cancers and the use of glucose-lowering therapies was also investigated. Results During the 7-year follow-up period, GI cancers developed in 929 diabetic patients (2.35%) and 1,126 subjects (1.42%) in the comparison cohort. DM was associated with a 2.75-fold (95% confidence interval (CI), 2.51-3.02) higher risk of developing GI malignancy. Among GI cancers, the incidences of stomach (adjusted hazard ratio (HR), 1.49; 95% CI, 1.16-1.92), liver (adjusted HR, 2.65; 95% CI, 2.29-3.07), colon (adjusted HR, 1.58; 95% CI, 1.28-1.94) and pancreatic cancers (adjusted HR, 4.35; 95% CI, 2.93-6.47) were significantly increased in the patients with DM. An analysis of the effects of various glucose-lowering therapies in the diabetic patients revealed the use of α-glucosidase inhibitors to be associated with a lower risk of hepatic cancer (adjusted HR, 0.62; 95% CI, 0.4-0.94). Thiazolidinedione (TZD) treatment was associated with lower stomach (adjusted HR, 0.11; 95% CI, 0.02-0.82) and hepatic cancer risks (adjusted HR, 0.46; 95% CI, 0.29-0.73), while sulfonylurea use was associated with a lower colon cancer risk (adjusted HR, 0.74; 95% CI, 0.51-1.09) and a higher pancreatic cancer risk (adjusted HR, 2.36; 95% CI, 1.21-4.61). Conclusion Patients with DM have an increased risk of GI malignancy that may be affected by the use of different categories of glucose-lowering therapies." @default.
• W2079334384 created "2016-06-24" @default.
• W2079334384 creator A5012296972 @default.
• W2079334384 creator A5027453448 @default.
• W2079334384 creator A5043297858 @default.
• W2079334384 creator A5046649512 @default.
• W2079334384 creator A5051760777 @default.
• W2079334384 creator A5065824923 @default.
• W2079334384 creator A5084063477 @default.
• W2079334384 creator A5085342962 @default.
• W2079334384 creator A5091410018 @default.
• W2079334384 date "2013-01-01" @default.
• W2079334384 modified "2023-10-11" @default.
• W2079334384 title "Increased Risk of Gastrointestinal Malignancy in Patients with Diabetes Mellitus and Correlations with Anti-Diabetes Drugs: A Nationwide Population-based Study in Taiwan" @default.
• W2079334384 cites W1969356473 @default.
• W2079334384 cites W1974816905 @default.
• W2079334384 cites W1982380405 @default.
• W2079334384 cites W1992752955 @default.
• W2079334384 cites W2019515706 @default.
• W2079334384 cites W2023223445 @default.
• W2079334384 cites W2026967508 @default.
• W2079334384 cites W2028212562 @default.
• W2079334384 cites W2028996544 @default.
• W2079334384 cites W2044513757 @default.
• W2079334384 cites W2048412570 @default.
• W2079334384 cites W2056439450 @default.
• W2079334384 cites W2056854271 @default.
• W2079334384 cites W2060356641 @default.
• W2079334384 cites W2072554852 @default.
• W2079334384 cites W2074235518 @default.
• W2079334384 cites W2088231412 @default.
• W2079334384 cites W2093870492 @default.
• W2079334384 cites W2104168724 @default.
• W2079334384 cites W2126919962 @default.
• W2079334384 cites W2169214947 @default.
• W2079334384 doi "https://doi.org/10.2169/internalmedicine.52.8276" @default.
• W2079334384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23648711" @default.
• W2079334384 hasPublicationYear "2013" @default.
• W2079334384 type Work @default.
• W2079334384 sameAs 2079334384 @default.
• W2079334384 citedByCount "40" @default.
• W2079334384 countsByYear W20793343842013 @default.
• W2079334384 countsByYear W20793343842014 @default.
• W2079334384 countsByYear W20793343842015 @default.
• W2079334384 countsByYear W20793343842016 @default.
• W2079334384 countsByYear W20793343842017 @default.
• W2079334384 countsByYear W20793343842018 @default.
• W2079334384 countsByYear W20793343842019 @default.
• W2079334384 countsByYear W20793343842020 @default.
• W2079334384 countsByYear W20793343842021 @default.
• W2079334384 countsByYear W20793343842022 @default.
• W2079334384 countsByYear W20793343842023 @default.
• W2079334384 crossrefType "journal-article" @default.
• W2079334384 hasAuthorship W2079334384A5012296972 @default.
• W2079334384 hasAuthorship W2079334384A5027453448 @default.
• W2079334384 hasAuthorship W2079334384A5043297858 @default.
• W2079334384 hasAuthorship W2079334384A5046649512 @default.
• W2079334384 hasAuthorship W2079334384A5051760777 @default.
• W2079334384 hasAuthorship W2079334384A5065824923 @default.
• W2079334384 hasAuthorship W2079334384A5084063477 @default.
• W2079334384 hasAuthorship W2079334384A5085342962 @default.
• W2079334384 hasAuthorship W2079334384A5091410018 @default.
• W2079334384 hasBestOaLocation W20793343841 @default.
• W2079334384 hasConcept C120665830 @default.
• W2079334384 hasConcept C121332964 @default.
• W2079334384 hasConcept C121608353 @default.
• W2079334384 hasConcept C126322002 @default.
• W2079334384 hasConcept C134018914 @default.
• W2079334384 hasConcept C201903717 @default.
• W2079334384 hasConcept C207103383 @default.
• W2079334384 hasConcept C2779399171 @default.
• W2079334384 hasConcept C2908647359 @default.
• W2079334384 hasConcept C44249647 @default.
• W2079334384 hasConcept C555293320 @default.
• W2079334384 hasConcept C61511704 @default.
• W2079334384 hasConcept C71924100 @default.
• W2079334384 hasConcept C72563966 @default.
• W2079334384 hasConcept C90924648 @default.
• W2079334384 hasConcept C99454951 @default.
• W2079334384 hasConceptScore W2079334384C120665830 @default.
• W2079334384 hasConceptScore W2079334384C121332964 @default.
• W2079334384 hasConceptScore W2079334384C121608353 @default.
• W2079334384 hasConceptScore W2079334384C126322002 @default.
• W2079334384 hasConceptScore W2079334384C134018914 @default.
• W2079334384 hasConceptScore W2079334384C201903717 @default.
• W2079334384 hasConceptScore W2079334384C207103383 @default.
• W2079334384 hasConceptScore W2079334384C2779399171 @default.
• W2079334384 hasConceptScore W2079334384C2908647359 @default.
• W2079334384 hasConceptScore W2079334384C44249647 @default.
• W2079334384 hasConceptScore W2079334384C555293320 @default.
• W2079334384 hasConceptScore W2079334384C61511704 @default.
• W2079334384 hasConceptScore W2079334384C71924100 @default.
• W2079334384 hasConceptScore W2079334384C72563966 @default.
• W2079334384 hasConceptScore W2079334384C90924648 @default.
• W2079334384 hasConceptScore W2079334384C99454951 @default.
• W2079334384 hasIssue "9" @default.
• W2079334384 hasLocation W20793343841 @default.
• W2079334384 hasLocation W20793343842 @default.

• next